[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global and United States Insulin Market Research by Company, Type & Application 2013-2025

April 2018 | 102 pages | ID: G8E98D2C5CDEN
HeyReport

US$ 2,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Insulin (from the Latin, insula meaning island) is a peptide hormone produced by beta cells of the pancreatic islets. It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of, especially, glucose from the blood into fat, liver and skeletal muscle cells.In these tissues the absorbed glucose is converted into either glycogen via glycogenesis or fats (triglycerides) via lipogenesis, or, in the case of the liver, into both.Glucose production (and excretion into the blood) by the liver is strongly inhibited by high concentrations of insulin in the blood.Circulating insulin also affects the synthesis of proteins in a wide variety of tissues. It is therefore an anabolic hormone, promoting the conversion of small molecules in the blood into large molecules inside the cells. Low insulin levels in the blood have the opposite effect by promoting widespread catabolism.

Market Segment as follows:

By Type
  • Ultra-short-acting insulin
  • Short-acting insulin
  • In effect insulin
  • Long-acting insulin
By Application
  • Type 1 diabetes
  • Type 2 diabetes
  • Others diabetes
By Company
  • Novartis
  • Novo Nordisk
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Eli Lilly
  • MannKind
  • Sanofi
  • Merck
  • Bioton
  • GEA
  • Emisphere
  • Salix Pharmaceuticals
  • Gan & Lee
  • Dongbao
  • United Laboratories (TUL)
  • Takeda Pharmaceutical Company
  • Shihuida PHARMA Group
  • Henan Tian Fang Pharmaceutical
  • Disha Pharmaceutical Group
The main contents of the report including:

Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
1 MARKET OVERVIEW

1.1 Market Segment Overview
  1.1.1 Product Definition
  1.1.2 Market by Type
    1.1.2.1 Ultra-short-acting insulin
    1.1.2.2 Short-acting insulin
    1.1.2.3 In effect insulin
    1.1.2.4 Long-acting insulin
  1.1.3 Market by Application
    1.1.3.1 Type 1 diabetes
    1.1.3.2 Type 2 diabetes
    1.1.3.3 Others diabetes
1.2 Global and Regional Market Size
  1.2.1 Global Overview
  1.2.2 United States Overview

2 GLOBAL AND REGIONAL MARKET BY COMPANY

2.1 Global
  2.1.1 Global Sales by Company
  2.1.2 Global Price by Company
2.2 United States
  2.2.1 United States Sales by Company
  2.2.2 United States Price by Company

3 GLOBAL AND REGIONAL MARKET BY TYPE

3.1 Global
  3.1.1 Global Sales by Type
  3.1.2 Global Price by Type
3.2 United States
  3.2.1 United States Sales by Type
  3.2.2 United States Price by Type

4 GLOBAL AND REGIONAL MARKET BY APPLICATION

4.1 Global
  4.1.1 Global Sales by Application
  4.1.2 Global Price by Application
4.2 United States
  4.2.1 United States Sales by Application
  4.2.2 United States Price by Application

5 REGIONAL TRADE

5.1 Export
5.2 Import

6 KEY MANUFACTURERS

6.1 Novartis
  6.1.2 Company Information
  6.1.2 Product Specifications
  6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Novo Nordisk
  6.2.1 Company Information
  6.2.2 Product Specifications
  6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Boehringer Ingelheim
  6.3.1 Company Information
  6.3.2 Product Specifications
  6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Bristol-Myers Squibb
  6.4.1 Company Information
  6.4.2 Product Specifications
  6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Eli Lilly
  6.5.1 Company Information
  6.5.2 Product Specifications
  6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 MannKind
  6.6.1 Company Information
  6.6.2 Product Specifications
  6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Sanofi
  6.7.1 Company Information
  6.7.2 Product Specifications
  6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Merck
  6.8.1 Company Information
  6.8.2 Product Specifications
  6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Bioton
  6.9.1 Company Information
  6.9.2 Product Specifications
  6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 GEA
  6.10.1 Company Information
  6.10.2 Product Specifications
  6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 Emisphere
6.12 Salix Pharmaceuticals
6.13 Gan & Lee
6.14 Dongbao
6.15 United Laboratories (TUL)
6.16 Takeda Pharmaceutical Company
6.17 Shihuida PHARMA Group
6.18 Henan Tian Fang Pharmaceutical
6.19 Disha Pharmaceutical Group

7 INDUSTRY UPSTREAM

7.1 Industry Chain
7.2 Raw Materials

8 MARKET ENVIRONMENT

8.1 SWOT
8.2 Porter's Five Forces

9 CONCLUSION

LIST OF TABLES

Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis
Table Sales Revenue, Volume, Price, Cost and Margin of Novo Nordisk
Table Sales Revenue, Volume, Price, Cost and Margin of Boehringer Ingelheim
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Table Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly
Table Sales Revenue, Volume, Price, Cost and Margin of MannKind
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Table Sales Revenue, Volume, Price, Cost and Margin of Merck
Table Sales Revenue, Volume, Price, Cost and Margin of Bioton
Table Sales Revenue, Volume, Price, Cost and Margin of GEA
Table Sales Revenue, Volume, Price, Cost and Margin of Emisphere
Table Sales Revenue, Volume, Price, Cost and Margin of Salix Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Gan & Lee
Table Sales Revenue, Volume, Price, Cost and Margin of Dongbao
Table Sales Revenue, Volume, Price, Cost and Margin of United Laboratories (TUL)
Table Sales Revenue, Volume, Price, Cost and Margin of Takeda Pharmaceutical Company
Table Sales Revenue, Volume, Price, Cost and Margin of Shihuida PHARMA Group
Table Sales Revenue, Volume, Price, Cost and Margin of Henan Tian Fang Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of Disha Pharmaceutical Group


LIST OF FIGURES

Figure Ultra-short-acting insulin Market Size and CAGR 2013-2017 (Million USD)
Figure Ultra-short-acting insulin Market Size and CAGR 2013-2017 (Volume)
Figure Ultra-short-acting insulin Market Forecast and CAGR 2018-2025 (Million USD)
Figure Ultra-short-acting insulin Market Forecast and CAGR 2018-2025 (Volume)
Figure Short-acting insulin Market Size and CAGR 2013-2017 (Million USD)
Figure Short-acting insulin Market Size and CAGR 2013-2017 (Volume)
Figure Short-acting insulin Market Forecast and CAGR 2018-2025 (Million USD)
Figure Short-acting insulin Market Forecast and CAGR 2018-2025 (Volume)
Figure In effect insulin Market Size and CAGR 2013-2017 (Million USD)
Figure In effect insulin Market Size and CAGR 2013-2017 (Volume)
Figure In effect insulin Market Forecast and CAGR 2018-2025 (Million USD)
Figure In effect insulin Market Forecast and CAGR 2018-2025 (Volume)
Figure Long-acting insulin Market Size and CAGR 2013-2017 (Million USD)
Figure Long-acting insulin Market Size and CAGR 2013-2017 (Volume)
Figure Long-acting insulin Market Forecast and CAGR 2018-2025 (Million USD)
Figure Long-acting insulin Market Forecast and CAGR 2018-2025 (Volume)
Figure Type 1 diabetes Market Size and CAGR 2013-2017 (Million USD)
Figure Type 1 diabetes Market Size and CAGR 2013-2017 (Volume)
Figure Type 1 diabetes Market Forecast and CAGR 2018-2025 (Million USD)
Figure Type 1 diabetes Market Forecast and CAGR 2018-2025 (Volume)
Figure Type 2 diabetes Market Size and CAGR 2013-2017 (Million USD)
Figure Type 2 diabetes Market Size and CAGR 2013-2017 (Volume)
Figure Type 2 diabetes Market Forecast and CAGR 2018-2025 (Million USD)
Figure Type 2 diabetes Market Forecast and CAGR 2018-2025 (Volume)
Figure Others diabetes Market Size and CAGR 2013-2017 (Million USD)
Figure Others diabetes Market Size and CAGR 2013-2017 (Volume)
Figure Others diabetes Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others diabetes Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Insulin Market Size and CAGR 2013-2017 (Million USD)
Figure Global Insulin Market Size and CAGR 2013-2017 (Volume)
Figure Global Insulin Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Insulin Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Insulin Market Size and CAGR 2013-2017 (Million USD)
Figure United States Insulin Market Size and CAGR 2013-2017 (Volume)
Figure United States Insulin Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Insulin Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Insulin SWOT List
Figure Healthcare & Medical Porter's Five Forces


More Publications